Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

The Need for Multi-Omics Biomarker Signatures in Precision Medicine.

Olivier M, Asmis R, Hawkins GA, Howard TD, Cox LA.

Int J Mol Sci. 2019 Sep 26;20(19). pii: E4781. doi: 10.3390/ijms20194781. Review.

2.

Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.

Pecak M, Korošec P, Kunej T.

OMICS. 2018 Jun;22(6):392-409. doi: 10.1089/omi.2018.0036.

PMID:
29927718
3.

Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.

Tebani A, Afonso C, Marret S, Bekri S.

Int J Mol Sci. 2016 Sep 14;17(9). pii: E1555. doi: 10.3390/ijms17091555. Review.

4.

Omics Profiling in Precision Oncology.

Yu KH, Snyder M.

Mol Cell Proteomics. 2016 Aug;15(8):2525-36. doi: 10.1074/mcp.O116.059253. Epub 2016 Apr 20. Review.

5.

Using omics approaches to understand pulmonary diseases.

Kan M, Shumyatcher M, Himes BE.

Respir Res. 2017 Aug 3;18(1):149. doi: 10.1186/s12931-017-0631-9. Review.

6.

Integrative methods for analyzing big data in precision medicine.

Gligorijević V, Malod-Dognin N, Pržulj N.

Proteomics. 2016 Mar;16(5):741-58. doi: 10.1002/pmic.201500396. Review.

7.

Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.

Umelo IA, Costanza B, Castronovo V.

Cancer Metastasis Rev. 2018 Mar;37(1):125-145. doi: 10.1007/s10555-017-9710-0. Review.

8.

Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.

Joshi MS, Montgomery KA, Giannone PJ, Bauer JA, Hanna MH.

Pediatr Res. 2017 Jan;81(1-2):271-276. doi: 10.1038/pr.2016.206. Epub 2016 Oct 10. Review.

PMID:
27723726
9.

Integrative Personal Omics Profiles during Periods of Weight Gain and Loss.

Piening BD, Zhou W, Contrepois K, Röst H, Gu Urban GJ, Mishra T, Hanson BM, Bautista EJ, Leopold S, Yeh CY, Spakowicz D, Banerjee I, Chen C, Kukurba K, Perelman D, Craig C, Colbert E, Salins D, Rego S, Lee S, Zhang C, Wheeler J, Sailani MR, Liang L, Abbott C, Gerstein M, Mardinoglu A, Smith U, Rubin DL, Pitteri S, Sodergren E, McLaughlin TL, Weinstock GM, Snyder MP.

Cell Syst. 2018 Feb 28;6(2):157-170.e8. doi: 10.1016/j.cels.2017.12.013. Epub 2018 Jan 17.

10.

Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.

Schena FP, Serino G, Sallustio F, Falchi M, Cox SN.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2101-2112. doi: 10.1093/ndt/gfy130. Review.

PMID:
29905852
11.

Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.

Ogino S, Nishihara R, VanderWeele TJ, Wang M, Nishi A, Lochhead P, Qian ZR, Zhang X, Wu K, Nan H, Yoshida K, Milner DA Jr, Chan AT, Field AE, Camargo CA Jr, Williams MA, Giovannucci EL.

Epidemiology. 2016 Jul;27(4):602-11. doi: 10.1097/EDE.0000000000000471.

12.

MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine.

Xie B, Yuan Z, Yang Y, Sun Z, Zhou S, Fang X.

Breast Cancer Res Treat. 2018 Jun;169(3):625-632. doi: 10.1007/s10549-018-4708-z. Epub 2018 Feb 10. Review.

PMID:
29429018
13.

Integrative omics for health and disease.

Karczewski KJ, Snyder MP.

Nat Rev Genet. 2018 May;19(5):299-310. doi: 10.1038/nrg.2018.4. Epub 2018 Feb 26. Review.

14.

Online tools for bioinformatics analyses in nutrition sciences.

Malkaram SA, Hassan YI, Zempleni J.

Adv Nutr. 2012 Sep 1;3(5):654-65. doi: 10.3945/an.112.002477. Review.

15.

The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics".

Ciocan-Cartita CA, Jurj A, Buse M, Gulei D, Braicu C, Raduly L, Cojocneanu R, Pruteanu LL, Iuga CA, Coza O, Berindan-Neagoe I.

Int J Mol Sci. 2019 May 25;20(10). pii: E2576. doi: 10.3390/ijms20102576. Review.

16.

New mass spectrometry technologies contributing towards comprehensive and high throughput omics analyses of single cells.

Couvillion SP, Zhu Y, Nagy G, Adkins JN, Ansong C, Renslow RS, Piehowski PD, Ibrahim YM, Kelly RT, Metz TO.

Analyst. 2019 Jan 28;144(3):794-807. doi: 10.1039/c8an01574k. Review.

17.

Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.

Hsieh JJ, Le V, Cao D, Cheng EH, Creighton CJ.

J Pathol. 2018 Apr;244(5):525-537. doi: 10.1002/path.5022. Epub 2018 Feb 14. Review.

PMID:
29266437
18.

The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.

Cisek K, Krochmal M, Klein J, Mischak H.

Nephrol Dial Transplant. 2016 Dec;31(12):2003-2011. doi: 10.1093/ndt/gfv364. Epub 2015 Oct 20. Review.

PMID:
26487673
19.
20.

Defining Cell Identity with Single-Cell Omics.

Mincarelli L, Lister A, Lipscombe J, Macaulay IC.

Proteomics. 2018 Sep;18(18):e1700312. doi: 10.1002/pmic.201700312. Epub 2018 May 28. Review.

Supplemental Content

Support Center